Pharmaceuticals
NanoCellect Biomedical Expands Distribution to Australia and New Zealand
Company enters exclusive agreement with Millennium Science Pty Ltd SAN DIEGO, California, July 24, 2019 /PRNewswire/ -- NanoCellect Biomedical Inc., a leader in the development and manufacture of microfluidic cell sorting solutions for cell-based assays, today announced an exclusive agreement wit...
2019-07-24 21:57
1772
111 Signs Strategic Cooperation with Harbin Pharmaceutical Group
SHANGHAI, July 24, 2019 /PRNewswire/ -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, today announced the signing of a strategic cooperation agreement with Harbin Pharmaceutical Group Holding Co., Ltd. (HPGC, SHSE: 600664), which has...
2019-07-24 20:00
8236
SINOMED® Concludes Enrollment of the PIONEER III Randomized, Pivotal Study of the BuMA Supreme® Coronary Drug-Eluting Stent
TIANJIN, China, July 23, 2019 /PRNewswire/ -- In a significant milestone toward obtaining key regulatory approvals for the BuMA Supreme Drug-Eluting Stent (DES) System, SINOMED has completed enrollment in the PIONEER III randomized, controlled clinical trial. The PIONEER III trial is designed to...
2019-07-23 15:00
2898
Huge CPhI & P-MEC China a direct result of surging manufacturing
SHANGHAI, July 23, 2019 /PRNewswire/ -- CPhI and P-MEC China – organized by China Chamber of Commerce for Import & Export of Medicines & Health Products (CCCMHPIE), Informa Markets, andShanghai Sinoexpo Informa Markets – saw record numbers of attendees as the pharma market inChina continues to gr...
2019-07-23 13:18
2311
WuXi STA Shanghai & Changzhou Facilities Pass U.S. FDA Inspections
SHANGHAI, July 23, 2019 /PRNewswire/ -- STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – announces that its Analytical Service Unit (ASU) inShanghai and active pharmaceutical ingredient (API) process R&D and manufacturing facility in Changzhou, have successfully passed two...
2019-07-23 12:48
3435
CStone receives approval in China to initiate ivosidenib Phase I bridging registrational study for the treatment of IDH1 mutant relapsed or refractory AML
SUZHOU, China, July 22, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone"; HKEX: 2616) announced today that it has received approval from China National Medical Products Administration (NMPA) to initiate a Phase I bridging registrational study of ivosidenib (TIBSOVO) for the treatment of rela...
2019-07-22 12:17
7267
Ascentage Pharma to Initiate Phase Ib Study of HQP1351 in Tyrosine Kinase Inhibitors -resistant Chronic Myeloid Leukemia Patients in the US
SUZHOU, China and ROCKVILLE, Md., July 22, 2019 /PRNewswire/ -- Ascentage Pharma, a globally-focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, hepatitis B virus and age-related diseases, today announced that the company was notified by the U.S. Food ...
2019-07-22 07:00
3064
Celltrion and Nan Fung Group to establish Vcell Healthcare Limited to Develop and Commercialize Biosimilars in China
INCHEON, South Korea and HONG KONG, July 19, 2019 /PRNewswire/ -- Celltrion and Nan Fung Group announced today the establishment of Vcell Healthcare Limited, a Joint Venture company between both parties. At the formation of the Joint Venture, Vcell Healthcare Limited has simultaneously signed a ...
2019-07-19 08:00
3879
Janssen Korea Ltd. and Johnson & Johnson Innovation Announce Launch of Seoul Innovation QuickFire Challenge in Smart Healthcare in Collaboration with Seoul Metropolitan Government and Korea Health Industry Development Institute
- QuickFire Challenge seeks to identify and accelerate game-changing, early-stage health tech innovations from around the world. - Awardees will receive up to KRW150,000,000 (approximately US $134,000), residence at the Seoul Bio Hub, mentorship and coaching, and access to the Johnson & Johnson...
2019-07-18 07:00
4261
Yuyu Pharma Receives Recognition for Outstanding Company Culture in Korea
SEOUL, South Korea, July 17, 2019 /PRNewswire/ -- Yuyu Pharma has received recognition as a Great Place to Work from the mayor of Jechoen city. The company also supported a recent HeForShe movement sponsored by the city of Jechoen. HeforShe is an UN-led gender equality movement that focuses on th...
2019-07-17 21:00
2618
The Menarini Group Celebrates the Champions of Fair Play
FLORENCE, Italy, July 16, 2019 /PRNewswire/ -- Two days dedicated to sport and the greater values of Fair Play. Last July the city ofFlorence hosted the XXIII^ edition of the International Fair Play Menarini Award: the annual event which celebrates those sporting champions who have stood out in t...
2019-07-16 15:00
3850
Merck's Embracing Carers™ Launches 'Time Counts' to Raise 1 Million Minutes of Support for Carers
DARMSTADT, Germany, July 16, 2019 /PRNewswire/ -- Merck, a leading science and technology company, today announced that its Embracing Carers™ initiative has launched 'Time Counts,' a social media-led video series asking friends and families of carers to collectively give 1 million minutes of thei...
2019-07-16 15:00
2763
Cipla EU and Jiangsu Acebright Enter Into Joint Venture
MUMBAI & JIANGSU, China, July 16, 2019 /PRNewswire/ -- Cipla (EU) Limited, ("Cipla EU"), a U.K.-based wholly-owned subsidiary of the leading global pharmaceutical company Cipla Limited (BSE: 500087) (NSE: CIPLA EQ) (hereafter referred to as "Cipla") and Jiangsu Acebright Pharmaceutical Co. Ltd....
2019-07-16 11:22
6047
Yuyu Pharma held the campaign for enhancing corporate transparency
SEOUL, South Korea, July 10, 2019 /PRNewswire/ -- Yuyu Pharma, a Korean
pharmaceutical company celebrated its third year of implementing Yuyu's
compliance management system by inviting senior management to its
"Self-Compliance Day" workshop.
2019-07-11 16:43
2363
MacroGenics and I-Mab Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Enoblituzumab in Greater China
ROCKVILLE, Md. and SHANGHAI, July 10, 2019 /PRNewswire/ -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, and I-Mab Biopharma (I-Mab), aChina and U.S....
2019-07-11 04:01
2413
SI Group Announces Focused Sale Of Industrial Resin Business to ASK Chemicals
SCHENECTADY, New York, July 10, 2019 /PRNewswire/ -- SI Group, a leading global developer and manufacturer of performance additives, process solutions, pharmaceuticals and chemical intermediates, announced today an agreement to sell the majority of its global industrial resin businesses and its B...
2019-07-10 22:00
3936
Healthcare Startup One BioMed closes US$5M Series A Funding Round
SINGAPORE, July 10, 2019 /PRNewswire/ -- One BioMed Pte Ltd, a Singapore-based medical diagnostics company, announced today that it has closed aUS$5 million Series A financing round, led bySingapore-based Biopath Ventures and US-based ARCH Venture Partners, with Enterprise Singapore's investment ...
2019-07-10 19:12
3571
Hummingbird Bioscience Closes Extended Series A Financing To Advance Clinical Pipeline
SINGAPORE, July 10, 2019 /PRNewswire/ -- Hummingbird Bioscience, a Singapore founded biotech company focused on the discovery and development of novel antibody-based therapeutics, today announced the successful completion of an extended Series A financing round. The round was led by Heritas Capit...
2019-07-10 15:09
2880
CStone announces first patient dosed in China with avapritinib in global Phase III clinical trial in advanced GIST
SUZHOU, China, July 9, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone", HKEX: 2616) today announced that the first patient has been dosed inChina with avapritinib in the ongoing global Phase III VOYAGER clinical trial. This study is designed to evaluate the safety and efficacy of avapritini...
2019-07-10 10:23
7615
Medeon Led and Completed Investments in Panther Orthopedics and Prodeon
TAIPEI, , July 8, 2019 /PRNewswire/ -- Medeon Biodesign, Inc. (TPEx: 6499), aTaiwan publicly traded medical device company, is pleased to announce that it recently led and closed two investments, in Panther Orthopedics and Prodeon. Panther Orthopedics is a Silicon Valley startup company pioneerin...
2019-07-08 17:10
13675
Week's Top Stories
Most Reposted
Another 'Reason to Travel': Agoda and Singapore Tourism Board Renew Partnership to Boost Travel to Singapore
[Picked up by 350 media titles]
2024-06-19 11:00
MIFB 2024 ENLISTS F&B EXPERTS TO SPEAK ON THE LATEST IN INDUSTRY TRENDS AND THE FUTURE OF FOOD
[Picked up by 335 media titles]
2024-06-20 16:24
New Study Finds Cybersecurity as Top Concern Among Automotive Manufacturers
[Picked up by 317 media titles]
2024-06-19 08:05k-ID Closes $45 Million Series A from Andreessen Horowitz and Lightspeed Venture Partners to Set a New Global Benchmark for Age-appropriate Gaming Experiences
[Picked up by 317 media titles]
2024-06-25 21:00
THEIR ROYAL HIGHNESSES THE DUKE AND DUCHESS OF EDINBURGH CELEBRATE THE GRAND OPENING OF THE PENINSULA LONDON, BELGRAVIA
[Picked up by 313 media titles]
2024-06-19 11:38
Most Read
Another 'Reason to Travel': Agoda and Singapore Tourism Board Renew Partnership to Boost Travel to Singapore
2024-06-19 11:00
15576
MIFB 2024 ENLISTS F&B EXPERTS TO SPEAK ON THE LATEST IN INDUSTRY TRENDS AND THE FUTURE OF FOOD
2024-06-20 16:24
13163
New Study Finds Cybersecurity as Top Concern Among Automotive Manufacturers
2024-06-19 08:05
9412
